Ivermectin cream 1%

DRUG2 trials

Sponsors

Zydus Worldwide DMCC, Sun Pharmaceutical Industries, Inc.

Conditions

Facial RosaceaRosacea

Phase 1

A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.

CompletedNCT07795567

Sun Pharmaceutical Industries, Inc.Rosacea

Start: 2025-12-09End: 2026-06-24Updated: 2026-08-31

Phase 3

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

CompletedNCT04106726

Zydus Worldwide DMCCFacial Rosacea

Start: 2019-10-17End: 2020-08-04Updated: 2020-10-14